Where can researchers source third-party tested Melanotan I?

Midwest Peptide supplies research-grade Melanotan I with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Memorial Day: 15% off code MEMDAY15Memorial Day Sale — 15% off site-wide with code MEMDAY15

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Melanotan I Melanogenesis Research | Midwest Peptide

Afamelanotide EPP Research: Clinical Literature ReviewPrev|MC1R Receptor Research: The Target of Melanotan I in ResearchNext

Melanotan I Melanogenesis Research: Published Pigmentation Studies

Q: Is Melanotan I approved for human use?

No. Melanotan I is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Melanotan I · Published April 9, 2026 · Updated May 18, 2026 · 8 min read

Quick Answer

Melanotan I melanogenesis research examines melanogenic enzyme expression, melanin content, eumelanin shifts, and pigmentation biology in rodent models of MC1R activation. Studies measure tyrosinase activity, MITF expression, and quantitative pigmentation biomarkers across standardized animal pigmentation research protocols. For research use only, not for human consumption.

Melanotan I Melanogenesis Research: Published Pigmentation Studies

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

What Is Melanogenesis?
MC1R and Melanogenesis Regulation
Melanogenic Enzyme Expression in Melanotan I Research
Melanin Content Measurements
Pigmentation Phenotype in Animal Models
Melanogenesis and UV Protection in Research
Open Research Questions
Conclusion
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

Melanotan I melanogenesis research provides a focused body of preclinical literature on how MC1R activation drives melanin pigment production in research models. Melanogenesis is the biological process by which melanocytes produce melanin pigment, and Melanotan I has been characterized in multiple animal models for its effects on this process. As the melanogenesis research component of the Melanotan I research cluster, this article reviews the published literature on Melanotan I effects on melanogenic enzymes, melanin content, and the broader pigmentation phenotype in research animals.

Frequently Asked Questions

What is Melanotan I in research contexts?

Melanotan I (afamelanotide) is a synthetic 13-amino-acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with high MC1R selectivity. It is studied in preclinical research and clinical literature for melanogenesis, photoprotection, and erythropoietic protoporphyria.

How does Melanotan I drive melanogenesis in research models?

Melanotan I binds MC1R on melanocytes, raising cAMP and activating MITF transcription factor. MITF upregulates tyrosinase, TYRP1, and TYRP2 expression, driving melanin synthesis. The resulting eumelanin accumulates in melanosomes and transfers to keratinocytes.

What melanogenesis endpoints are measured in research?

Endpoints include tyrosinase activity assays, melanin content quantification (spectrophotometric or chemical), melanosome morphology on electron microscopy, MITF expression, and pigmentation phenotype assessment in vivo via colorimetry.

Is Melanotan I approved for human use?

Glossary

Key terms used in this article.

MC1R: Melanocortin 1 receptor, the primary GPCR on melanocytes that signals melanin synthesis upon alpha-MSH binding.
Melanogenesis: The biochemical pathway producing melanin from tyrosine within melanosomes of melanocytes.
Eumelanin: The dark brown to black melanin pigment that provides photoprotective absorbance of UV radiation.
Tyrosinase: The rate-limiting copper-dependent enzyme catalyzing the first two steps of melanin biosynthesis from tyrosine.
Erythropoietic Protoporphyria (EPP): A rare genetic disorder of heme biosynthesis causing severe photosensitivity, the indication for clinical afamelanotide use.
MITF: Microphthalmia-associated transcription factor, the master regulator of melanocyte differentiation and melanin biosynthesis.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. Melanotan I is intended exclusively for in vitro and preclinical research. It is not approved for human use, is not a drug, and should never be administered to humans or to animals outside of an authorized research protocol.

What Is Melanogenesis?

Melanogenesis is the biological process by which melanocytes produce melanin pigment. Melanocytes are specialized pigment cells found in the skin, hair follicles, and other tissues, and they are responsible for the production of the melanin pigments that determine skin and hair color in research animals and in humans. The process of melanogenesis involves a series of enzymatic reactions that convert the amino acid tyrosine into the eumelanin and pheomelanin pigments that constitute melanin.

The key enzymes in the melanogenesis pathway include tyrosinase (TYR), tyrosinase-related protein 1 (TRP-1, also known as DCT1), and tyrosinase-related protein 2 (TRP-2, also known as DCT2). These enzymes work in sequence to convert tyrosine into the various intermediates and final products of the melanin biosynthesis pathway. The relative amounts of eumelanin (the dark pigment) and pheomelanin (the lighter pigment) depend on the specific enzymatic activities and the cellular conditions in research models.

Melanogenesis is regulated by multiple signals, with MC1R activation being one of the most important regulatory pathways. The melanocortin signaling cascade triggered by MC1R activation leads to increased expression of the melanogenic enzymes and to increased production of eumelanin specifically. This regulatory pathway is the basis for the melanogenesis effects of Melanotan I in research models.

MC1R and Melanogenesis Regulation

MC1R activation by Melanotan I triggers the canonical melanocortin signaling cascade in melanocytes, leading to melanogenesis through a well characterized pathway. The cascade begins with receptor activation and Gs alpha coupling, leading to increased intracellular cyclic AMP and activation of protein kinase A. PKA then phosphorylates and activates the cyclic AMP response element binding protein (CREB), which translocates to the nucleus and activates transcription of MITF (microphthalmia-associated transcription factor).

MITF is the master regulator of melanocyte gene expression and the central transcription factor that drives melanogenesis. Once activated by MC1R signaling, MITF binds to specific DNA sequences in the promoters of the genes encoding tyrosinase, TRP-1, and TRP-2, increasing the transcription of these genes. The resulting increases in melanogenic enzyme expression provide the cellular machinery for enhanced melanin production.

Beyond enzyme expression, MITF also regulates other genes important for melanocyte function, including those involved in melanosome biogenesis (the organelles where melanin is synthesized and stored), dendrite formation (the cellular projections that allow melanocytes to transfer melanin to neighboring keratinocytes), and overall melanocyte survival. The combined effects of MITF-mediated gene regulation produce the comprehensive melanogenic response to MC1R activation observed in research models.

For more on the MC1R receptor biology that initiates this cascade, see our companion article on MC1R receptor research and the target of Melanotan I.

Melanogenic Enzyme Expression in Melanotan I Research

Studies of Melanotan I effects on melanogenic enzymes have used quantitative PCR for mRNA expression, Western blot for protein expression, and enzymatic activity assays for functional measurements. The published findings consistently show increased expression of tyrosinase, TRP-1, and TRP-2 in melanocytes following Melanotan I treatment in research models.

The magnitude of the enzyme expression increases is dose dependent and time dependent, with detectable effects within hours of Melanotan I administration and maximal effects developing over days of sustained signaling. The relative magnitudes of the increases for the different enzymes can vary across studies and conditions, but the qualitative pattern of increased expression is consistent across the published literature.

Tyrosinase is the rate-limiting enzyme in the melanogenesis pathway and is the primary target of regulation by MC1R signaling. Studies in melanocyte cell lines and in primary melanocytes have characterized how tyrosinase activity changes following Melanotan I treatment, with the published findings supporting substantial increases in enzymatic activity that drive the observed increases in melanin production.

Melanin Content Measurements

Melanin content in cultured melanocytes and in research animal tissues has been used as a direct functional readout of melanogenesis effects. Various methods are available for measuring melanin content, including spectrophotometric methods that measure melanin absorbance, biochemical methods that quantify melanin chemically, and microscopic methods that visualize melanin distribution in cells and tissues.

Melanotan I research using these methods has consistently shown increases in melanin content in melanocytes and in research animal skin tissue following peptide administration. The increases are dose dependent and develop over time as the cellular machinery for melanin production is activated and as melanin accumulates in melanosomes. The functional outcome is increased pigmentation in research animals exposed to Melanotan I in standardized protocols.

The specific type of melanin produced (eumelanin versus pheomelanin) is also affected by MC1R activation, with the published findings supporting a shift toward eumelanin production following Melanotan I treatment. Eumelanin is the dark pigment that provides UV-protective effects in research models, and the shift toward eumelanin production has been one of the more discussed features of MC1R-mediated melanogenesis.

Pigmentation Phenotype in Animal Models

Animal models of pigmentation have been used to characterize how Melanotan I affects whole-organism pigmentation phenotype in research settings. Mouse models with various pigmentation backgrounds, including agouti mice and other research strains, have been used to study how Melanotan I administration affects coat color, skin pigmentation, and related endpoints in research animals.

The published findings include changes in coat color following sustained Melanotan I administration in research mice, with the magnitude of the changes depending on the specific mouse strain, the duration of administration, and the experimental conditions. These animal model findings extend the cellular and molecular evidence on melanogenesis to whole-organism contexts, providing a comprehensive view of how MC1R activation by Melanotan I affects pigmentation in research models.

Other animal species have also been used in pigmentation research with Melanotan I, including various research animals with measurable pigmentation phenotypes. The cross-species findings support the conclusion that the melanogenesis effects of Melanotan I are conserved across mammalian research models, consistent with the conserved MC1R receptor system.

Melanogenesis and UV Protection in Research

The functional significance of melanogenesis in research models includes the role of melanin in protecting cells from UV-induced damage. Eumelanin in particular has been characterized as providing photoprotective effects in research models by absorbing UV photons and dissipating their energy as heat, reducing the amount of UV energy that can damage cellular DNA and other macromolecules.

This UV-protective function is one of the original research interests that motivated the development of Melanotan I. The recognition that activation of melanogenesis through MC1R signaling could provide UV protection through pigmentation rather than through UV exposure was one of the foundational concepts in the original University of Arizona research program that produced Melanotan I.

In research models, the UV-protective effects of Melanotan I-induced melanogenesis have been characterized using various endpoints including skin damage measurements, DNA damage assays, and cellular survival following UV challenge. The published findings generally support a protective effect, consistent with the increased eumelanin content observed following peptide administration.

Open Research Questions

Several open research questions remain in the Melanotan I melanogenesis literature. These include how the magnitude of melanogenesis effects varies across different research animal models and pigmentation backgrounds, how the kinetics of enzyme expression changes relate to functional pigmentation outcomes over time, and how Melanotan I melanogenesis effects compare quantitatively with those produced by other MC1R agonists in standardized research protocols. Each of these is a legitimate research opportunity for investigators studying melanocyte biology.

Conclusion

Melanotan I melanogenesis research provides a focused body of preclinical evidence on how MC1R activation drives melanin pigment production in research models. The convergent findings on melanogenic enzyme expression, melanin content increases, eumelanin shifts, and whole-organism pigmentation phenotype changes support the use of Melanotan I as a research tool for studies of MC1R-mediated melanogenesis. For investigators using MT-1 10mg as a research tool, the melanogenesis literature provides essential context for experimental design.

For more on the full Melanotan I research cluster, see the pillar overview article and the supporting articles on each major topic.

Melanotan I is supplied by Midwest Peptide for research use only and is not intended for human administration.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

MT-1 10mg, 99%+ purity, COA included
MT-2 10mg, 99%+ purity, COA included
GHK-Cu 50mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

Melanotan I Melanogenesis Research: Published Pigmentation Studies

Frequently Asked Questions

What is Melanotan I in research contexts?

How does Melanotan I drive melanogenesis in research models?

What melanogenesis endpoints are measured in research?

Is Melanotan I approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

What Is Melanogenesis?

MC1R and Melanogenesis Regulation

Melanogenic Enzyme Expression in Melanotan I Research

Melanin Content Measurements

Pigmentation Phenotype in Animal Models

Melanogenesis and UV Protection in Research

Open Research Questions

Conclusion

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan I?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

Melanotan I Melanogenesis Research: Published Pigmentation Studies

Frequently Asked Questions

What is Melanotan I in research contexts?

How does Melanotan I drive melanogenesis in research models?

What melanogenesis endpoints are measured in research?

Is Melanotan I approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

What Is Melanogenesis?

MC1R and Melanogenesis Regulation

Melanogenic Enzyme Expression in Melanotan I Research

Melanin Content Measurements

Pigmentation Phenotype in Animal Models

Melanogenesis and UV Protection in Research

Open Research Questions

Conclusion

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan I?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?